Publications by authors named "A C Goodeve"
Article Synopsis
- Von Willebrand factor (VWF) is essential for blood clotting, and mutations in this protein can cause von Willebrand disease (VWD), particularly the type 1 variant which is the most common bleeding disorder in humans.
- The study focused on investigating the genetic and clinical characteristics of VWD type 1 patients in eastern Saudi Arabia, specifically looking at exon 28 of the VWF gene and including both patients and their family members.
- While most genetic variants found were deemed benign, the research identified two pathogenic variants linked to more severe VWD symptoms in three patients, underscoring the importance of ongoing research into VWD genetics in this population.
Introduction: von Willebrand disease (VWD) is the most prevalent bleeding disease, which is associated with either low levels of von Willebrand factor (VWF) or abnormality in its structure. Three types of the disease have been described; type 1 (VWD1) and 3 (VWD3) are caused by deficiency of VWF and type 2 (VWD2) is caused by production of defective VWF. The aim of the current study was to characterize gene variants of gene; exon 18 in particular, in a cohort of Saudi families as well as healthy control subjects.
View Article and Find Full Text PDFType 3 von Willebrand disease (VWD3) is a rare and severe bleeding disorder characterized by often undetectable von Willebrand factor (VWF) plasma levels, a recessive inheritance pattern, and heterogeneous genotype. The objective of this study was to identify the VWF defects in 265 European and Iranian patients with VWD3 enrolled in 3WINTERS-IPS (Type 3 Von Willebrand International Registries Inhibitor Prospective Study). All analyses were performed in centralized laboratories.
View Article and Find Full Text PDFCopy number variation (CNV) is known to cause all von Willebrand disease (VWD) types, although the associated pathogenic mechanisms involved have not been extensively studied. Notably, in-frame CNV provides a unique opportunity to investigate how specific von Willebrand factor (VWF) domains influence the processing and packaging of the protein. Using multiplex ligation-dependent probe amplification, this study determined the extent to which CNV contributed to VWD in the Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease cohort, highlighting in-frame deletions of exons 3, 4-5, 32-34, and 33-34.
View Article and Find Full Text PDFBackground: Type 3 von Willebrand's disease (VWD) patients present markedly reduced levels of von Willebrand factor and factor VIII. Because of its rarity, the bleeding phenotype of type 3 VWD is poorly described, as compared to type 1 VWD.
Aims: To evaluate the frequency and the severity of bleeding symptoms across age and sex groups in type 3 patients and to compare these with those observed in type 1 VWD patients to investigate any possible clustering of bleeding symptoms within type 3 patients.